Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Horizon Therapeutics (HZNP)

47.58   -1.24 (-2.54%) 06-04 16:00
Open: 48.34 Pre. Close: 48.82
High: 48.71 Low: 46.79
Volume: 2,695,569 Market Cap: 9,077M
Horizon Pharma PLC is a pharmaceutical company. The company focuses on researching, developing and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 48.768 - 49.073 49.073 - 49.288
Low: 46.077 - 46.452 46.452 - 46.717
Close: 47.084 - 47.637 47.637 - 48.027

Technical analysis

as of: 2020-06-04 4:32:24 PM
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 59.45     One year: 69.44
Support: Support1: 40.76    Support2: 34.50
Resistance: Resistance1: 50.90    Resistance2: 59.45
Pivot: 48.25
Moving Average: MA(5): 49.47     MA(20): 47.31
MA(100): 36.28     MA(250): 31.43
MACD: MACD(12,26): 3.11     Signal(9): 3.53
Stochastic oscillator: %K(14,3): 72.03     %D(3): 82.59
RSI: RSI(14): 60.22
52-week: High: 50.90  Low: 22.69  Change(%): 99.2
Average Vol(K): 3-Month: 244518  10-Days: 242704

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HZNP has closed above bottom band by 39.8%. Bollinger Bands are 13.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 30 May 2020
Is Horizon Therapeutics (HZNP) A Good Stock To Buy? - Yahoo Finance

Fri, 05 Jun 2020
Ocular Surgeon Sees Horizon Therapeutics (HZNP) Tepezza as Game Changing - Piper Sandler -

Thu, 07 May 2020
Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates - Yahoo Finance

Wed, 06 May 2020
Horizon Therapeutics PLC (HZNP) Q1 2020 Earnings Call Transcript - Motley Fool

Thu, 21 May 2020
Horizon Therapeutics Named Number One Best Workplace in Chicago - Business Wire

Wed, 06 May 2020
Horizon Therapeutics (HZNP) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 191
Shares Float (M) 177
% Held by Insiders 1.31
% Held by Institutions 91.66
Shares Short (K) 8,590
Shares Short P. Month (K) 6,650

Stock Financials

EPS 2.930
EPS Est This Year 1.070
EPS Est Next Year 1.250
Book Value (p.s.) 11.480
Profit Margin 43.06
Operating Margin 9.01
Return on Assets (ttm) 1.9
Return on Equity (ttm) 32.1
Qtrly Rev. Growth 26.9
Gross Profit (p.s.) 4.916
Sales Per Share 7.233
EBITDA (p.s.) 1.022
Qtrly Earnings Growth
Operating Cash Flow (M) 308
Levered Free Cash Flow (M) 95

Stock Valuations

PE Ratio 16.24
PEG Ratio
Price to Book value 4.14
Price to Sales 6.58
Price to Cash Flow 29.51

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.